These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 446410

  • 1. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L, Vijayan E, Coppings RJ, Giachetti A, McCann SM, Mayfield MA.
    Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
    [No Abstract] [Full Text] [Related]

  • 2. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L, McCann SM, Mayfield MA.
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [Abstract] [Full Text] [Related]

  • 3. Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat.
    Krulich L, Coppings RJ, Giachetti A, McCann SM, Mayfield MA.
    Neuroendocrinology; 1980 Apr; 30(3):133-8. PubMed ID: 6445044
    [Abstract] [Full Text] [Related]

  • 4. Involvement of brain serotonin in the prolactin-releasing effect of opioid peptides.
    Spampinato S, Locatelli V, Cocchi D, Vicentini L, Bajusz S, Ferri S, Müller EE.
    Endocrinology; 1979 Jul; 105(1):163-70. PubMed ID: 221198
    [No Abstract] [Full Text] [Related]

  • 5. Effects of quipazine on blood pressure in pithed rats.
    Shin YK, Svinareff P, Schmitt-Jubeau H, Schmitt H.
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [Abstract] [Full Text] [Related]

  • 6. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM, Gala RR.
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR, Noland V, Lowy MT, Nichols DE, Yim GK.
    Commun Psychopharmacol; 1978 Mar; 2(4):287-95. PubMed ID: 729354
    [No Abstract] [Full Text] [Related]

  • 8. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A, Antkiewicz-Michaluk L, Vetulani J.
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract] [Full Text] [Related]

  • 9. Further evidence that prolactin secretion in adult female rats is differently modified after neonatal estrogenization or androgenization: responses to methysergide, quipazine, and pizotifen.
    Collado D, Aguilar E.
    Physiol Behav; 1993 Jan; 53(1):161-5. PubMed ID: 8434056
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prolactin secretion by a direct effect of methysergide on the pituitary lactotrophs in the rat.
    Krulich L, Coppings RJ, McCann SM, Mayfield MA.
    Life Sci; 1978 Oct 23; 23(16):1665-73. PubMed ID: 723442
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin neuroleptics change patterns of preovulatory secretion of luteinizing hormone in rats.
    Walker RF.
    Life Sci; 1980 Sep 22; 27(12):1063-8. PubMed ID: 7191463
    [No Abstract] [Full Text] [Related]

  • 12. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB, Booth NH, Jernigan AD, Robbins JD, Hatch RC.
    Am J Vet Res; 1986 May 22; 47(5):1089-91. PubMed ID: 3717731
    [Abstract] [Full Text] [Related]

  • 13. Effects of parachlorophenylalanine, quipazine and cyproheptadine on growth hormone and adrenocorticotropin secretion in steers.
    Sartin JL, Kemppainen RJ, Marple DN, Carnes R, Dieberg G, Oliver EH.
    Domest Anim Endocrinol; 1987 Jan 22; 4(1):33-41. PubMed ID: 2853663
    [Abstract] [Full Text] [Related]

  • 14. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA, Kuhn CM.
    J Pharmacol Exp Ther; 1987 Mar 22; 240(3):825-30. PubMed ID: 3031276
    [Abstract] [Full Text] [Related]

  • 15. Opiate-serotonin synergism stimulating luteinizing hormone release in estrogen-progesterone-primed ovariectomized rats: mediation by serotonin2 receptors.
    Lenahan SE, Seibel HR, Johnson JH.
    Endocrinology; 1987 Apr 22; 120(4):1498-502. PubMed ID: 3830057
    [Abstract] [Full Text] [Related]

  • 16. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO, Johnson MD, Crowley WR.
    Life Sci; 1984 Oct 01; 35(14):1481-7. PubMed ID: 6148678
    [Abstract] [Full Text] [Related]

  • 17. The combined effect of quipazine and haloperidol on plasma prolactin release.
    Feigenbaum J, Yanai J, Klawans HL, Chatterton R.
    Int J Neurosci; 1983 Oct 01; 18(1-2):37-40. PubMed ID: 6840980
    [Abstract] [Full Text] [Related]

  • 18. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L, Panksepp J.
    Pharmacol Biochem Behav; 1985 May 01; 22(5):885-7. PubMed ID: 2989950
    [Abstract] [Full Text] [Related]

  • 19. On the central anti-serotoninergic actions of cyproheptadine and methysergide.
    Jacoby JH, Poulakos JJ, Bryce GF.
    Neuropharmacology; 1978 May 01; 17(4-5):299-306. PubMed ID: 652142
    [No Abstract] [Full Text] [Related]

  • 20. Complex role of 5-HT in the regulation of TSH secretion in the male rat.
    Mattila J, Männistö PT.
    Horm Res; 1981 May 01; 14(3):165-71. PubMed ID: 6456976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.